FDAnews
www.fdanews.com/articles/197649-oxford-trial-finds-dexamethasone-beneficial-for-covid-19
Respirator COVID-19 Patient doctor protection

Oxford Trial Finds Dexamethasone Beneficial for COVID-19

June 17, 2020

The University of Oxford’s RECOVERY trial found that dexamethasone provides a benefit in COVID-19 patients.

The dexamethasone arm of the trial demonstrated that the steroid reduced deaths by one-third in ventilated patients and by one-fifth in patients only receiving oxygen. There was no benefit for those who did not require respiratory support.

The results suggest that one death would be prevented for every eight ventilated patients treated and one in every 25 for patients receiving oxygen alone.

View today's stories